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Editorial Comment

To the heart of the problem. mIGF‐1: local effort for global impact
Antonio Musarò

since in the absence of SIRT1expression in cardiac
muscle, mIGF-1 activity could not protect the heart
from oxidative stress and lethality [6].

The mammalian heart must maintain its structural and
functional integrity for decades, yet the response to
damage in this vital organ is remarkably inadequate and
often results in heart failure. Moreover, patients with
chronic heart failure show profound metabolic changes,
leading to peripheral abnormalities in addition to an
initial cardiac impairment. Several evidences have
suggested a relationship between the IGF-1 system and
cardiovascular disease. Many cardiovascular risk
factors, such as sedentary lifestyle, diabetes, smoking,
oxidized low-density lipoprotein, obesity, psychological
distress and reduced coronary flow reserve, have been
associated with reduced IGF-1 levels [1]. Conversely,
human studies indicate that increased levels of IGF-1
are characterized by a decreased incidence of heart
failure and mortality in elderly individuals [2].
Nevertheless, the fact that IGF-1 can act either as a
circulating hormone or as a local growth factor has
confounded previous analyses of animal models in
which transgenic IGF synthesized in extra-hepatic
tissues was released into the circulation. Locally acting
mIGF-1 isoform improves muscle regeneration and
counters muscle wasting associated with diseases,
including sarcopenia, muscular dystrophy and ALS [3].
By contrast, circulating IGF-1 isoforms have been
implicated in the restriction of lifespan and have
contrasting effects on the heart when expressed as
transgenes, variously promoting cell survival, or
inducing prolonged hypertrophy with pathological
consequences [4]. Another important mediator of cell
homeostasis with cardio-protective effects is SIRT1, the
largest and best characterized member of the Sirtuin
family. Is there any functional interplay between IGF-1
signaling and SIRT1 expression and activity? The study
of Bolasco et al [5] addresses this point and offers
some fascinating insights into the molecular mechanism
by which the cardiac mIGF-1/SIRT1 pathway in mice,
has a global impact on the regulation of the immune
system, the arterial blood pressure and also the
behavioral response to fear. In their previous work, the
authors demonstrated that heart-specific transgenic
mIGF-1 mice are able to recover heart function after
damage by the modulation of inflammatory response,
enhancement of antioxidative cell defenses, and de novo
vascularization. This impact of IGF-1 on the mouse
heart may be operative through the activation of SIRT1,
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To explain why the cardiomyocytes of mIGF-1 mice
respond better to specific types of stress (e.g. ischemia,
angiotensin II, cardiotoxin injection, paraquat injection)
Bolasco et al performed transcriptomic analyses on the
hearts of mIGF‐1 transgenic versus wild type mice, in
absence of any injury. Interestingly, the variations in the
mIGF-1/SIRT1 genomic and transcriptomic effects
were related to genes implicated in the immune
response, the blood pressure control, inflammation and
behavior. This suggests that:
1)
IGF-1/SIRT1 pathway regulates functions
beyond cardiomyocyte specific homeostatic and
protective mechanisms,
2)
the cardioprotective mIGF-1/SIRT1 pathway
might elicit a global impact on body functions.
Of interest was the observation that in absence of
damage, local mIGF-1 cardiac expression induces an
up-regulation of relevant genes associated with the
regulation of immune function. How this “supra-basal”
activation of the immune system is compatible with a
better cardiac function?
The impact of cardioprotective mIGF-1 pathway on
immune and cardiovascular stress is coherent with the
concept of hormesis, which is an adaptive response of
cells and organisms to a moderate stress. Recent
findings have elucidated the cellular signaling pathways
and molecular mechanisms that mediate hormetic
responses which typically involve enzymes such as
kinases and deacetylases, and transcription factors [7].
In this context, SIRT1, an important member of the
Sirtuin family of nicotinamide adenine dinucleotide
(NAD+)-dependent protein deacetylases, might
participate in the hormetic response of mIGF-1 cardiac
muscle. The activation of the immune system, by
cardiac mIGF-1 expression, would also suggest that
mIGF-1 guarantees a constant turnover of cardiac stem
cells and cardiomyocytes. Of note, different studies of
the group of Rosenthal, Musarò and Vinciguerra clearly
indicated that mIGF-1 exerts its anabolic role, in both
cardiac and skeletal muscle, acting on stem cell
compartments. Another important and surprisingly
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finding of the study by Bolasco et al. was the
observation that mIGF-1 transgenic mice were mildly
hypertensive and this effect could be rescued by
cardiomyocyte specific depletion of SIRT1. Although
the authors did not define a causal link between high
blood pressure and cardiac mIGF-1/SIRT1 pathway, it
is possible that the activation of immune system plays a
critical role in the modulation of blood pressure. Indeed,
inflammation is recognized as an important factor in the
pathophysiology of hypertension [8]. Although the
hypertension is considered a pathologic events which
also favors a decline in memory, a study in centenarians
showed conversely that high blood pressure is
associated to improved cognitive functions [9].
Interestingly, Bolasco and collaborators demonstrated
that mice harboring mIGF-1 transgene in the heart had a
better memory of the aversive stimulus, for both cue
and context fear response, in that they spent a
significant augmented time in a frozen position
compared to wild type littermates. This was strictly
dependent on the presence of SIRT1.

7. Mattson MP. Ageing Res Rev. 2008; 7:1‐7.
8. Kasal DA, Schiffrin EL. Int J Hypertens. 2012; 2012:829786.
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24:299‐303.

Thus, a primed immune system can constitute an
hormetic advantage for responding to a potential cardiac
tissue damage. In this context, further studies should
better address the causes of hypertension, taking into
consideration epigenetic phenomena and environmental
factors. This would help to better define whether
essential hypertension could be replaced by other terms
with precise pathophysiological characteristics.
Together, these observations support hypothesis that the
mIGF-1/SIRT1 pathway maintains the “youth heart”
and renders the cardiac muscle more responsive and
resistant to different pathologic stimuli.
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